Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the noisy SpaceX creator and X owner. “The arrogance of these guys knows no limit,” grumbles ...
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have divulged stimulator of interferon genes protein (STING; TMEM173) antagonists reported to be useful for the treatment of cancer, autoimmune ...
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have described NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors reported to be useful for the treatment of neurodegeneration.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Wafaa Mamilli (1967) will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas Schinecker ...
Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat ...
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback